91Â鶹ÌìÃÀÖ±²¥

Stavros G. Drakos
No Rating Available
(Learn About Our Rating System)

Stavros G. Drakos, MD, PhD, FACC

Languages spoken: English, Modern Greek

Clinical Locations

University of Utah Hospital

Salt Lake City
801-585-5122

University of Utah Hospital

Heart Transplant Clinic
Salt Lake City
801-585-5122

University of Utah Hospital

Heart Failure Clinic
Salt Lake City
801-585-5122

Veterans Administration Medical Center

Salt Lake City
801-584-1235

  • Dr. Stavros George Drakos is a Professor of Cardiology and Physiology at the 91Â鶹ÌìÃÀÖ±²¥ & School of Medicine and holds the H. A. & Edna Benning Presidential Endowed Chair. He is the Medical Director of our institution's historic Cardiac Mechanical Support/Artificial Heart Program, Co-Director of the Heart Failure & Transplant section and Director of Research for the Division of Cardiology. Dr. Drakos is one of 27 cardiologists in the country being recognized by Forbes as an exemplary physician in the field of Cardiology.

    Dr. Drakos and his team published clinical studies in heart failure together with original scientific work generated in the laboratory which led to the establishment of the award-winning Utah Cardiac Recovery Program (UCAR). He is the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH and a visiting professor in academic medical centers nationally and internationally. He co-chairs the annual international Utah Cardiac Recovery Symposium (UCARS), the NIH Working Group on Myocardial Recovery and is an elected member of the ASCI (American Society of Clinical Investigation). Dr. Drakos has mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas.

    CLINICAL INFO

    Dr. Drakos is one of 27 cardiologists across the country being recognized by Forbes as an exemplary physician in the field of Cardiology (for more info click ).

    Earlier in his career he completed advanced heart failure and transplant training at the U of Utah (2001-2003) and after returning to the U of Athens in Greece he played a pivotal role in starting the first Ventricular Assist Device (VAD) program in the country (2003-2008) in collaboration with Sir Magdi Yacoub's team, Harefield/Imperial College London. Six years later (2008) he was recruited back at the U of Utah and since then he has been on faculty at the Division of Cardiology.

    What kind of patients Dr. Drakos sees?

    Dr. Drakos’ clinical specialties include Heart Failure and Cardiomyopathies, Heart Transplantation and Mechanical Circulatory Support (MCS/VAD). He is licensed to practice medicine in the US and the EU. He currently receives patient referrals and consultations from several states. To schedule an appointment please call 801-585-5122. For 12 years in a row, 91Â鶹ÌìÃÀÖ±²¥ has been ranked in the top 10 for Health Care Quality among major university hospitals in the US: /quality/

    ACADEMIC INFO

    Dr. Drakos’ research interests are focused on cardiac recovery in the chronic heart failure (HF) setting and the acute setting (i. e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Dr. Drakos' NIH-funded team is housed at the Nora Eccles Harrison Cardiovascular Research and Training Institute-CVRTI (). Original work generated by Dr. Drakos' team in the clinical arena and in his lab led to the establishment of the award-winning multidisciplinary Utah Cardiac Recovery Program-UCAR. To further advance the field of cardiac recovery Dr. Drakos is co-directing the annual international Utah Cardiac Recovery Symposium (UCARS) - for more info click . Along the same lines Dr. Drakos is co-chairing the NIH/NHLBI Working Group on Myocardial Recovery - its executive summary and member list can be found at: https://www.nhlbi.nih.gov/events/2016/nhlbi-working-group-advancing-science-myocardial-recovery-mechanical-circulatory - simultaneous publication at the official journals of the American College Cardiology, Heart Failure Society of America, American Association of Thoracic Surgery and the American Society of Artificial Internal Organs.

    TRAINING:

    1. Dr. Drakos started his medical training at the Univ. of Athens School of Medicine (most competitive academic institution in Greece: ) where he was admitted after scoring 3rd highest out of thousands pre-med students on the state boards. He received his Medical Degree (M. D. ) with Honors and went on to acquire a Ph. D under the mentorship of John N. Nanas, MD/PhD, a prior trainee of the U of Utah (Thesis entitled: 'Pulsatile vs. non-pulsatile mechanical circulatory support in a porcine model of heart failure', Award: 'Top PhD Thesis of the Year, U of Athens')

    2. Internal Medicine and General Cardiology Training: U of Athens (Mentors: John N. Nanas, MD/PhD, and Maria Anastasiou-Nanas, MD/PhD).

    3. Heart Failure/Transplant/MCS Fellowship: U of Utah, Intermountain Healthcare & Salt Lake VA Medical Center (Mentors: Dale G. Renlund, MD, and Elizabeth H. Hammond, MD).

    4. Harefield-UK Athens-Greece Cardiac Recovery Program (H. A. R. P. ), (Mentor: Sir Magdi H. Yacoub, MD)

    5. Cardiovascular Translational Research Fellowship: Molecular Medicine Program / Eccles Institute of Human Genetics, U of Utah (Mentor: Dean Y. Li, MD/PhD).

    NOW HIRING - WHY IN THE ACADEMIC ENVIRONMENT OF UTAH:

    From a historical perspective Dr. Drakos’ mentors, John Nanas, MD/PhD and Alex Kralios, MD/PhD, also came from the U of Athens and excelled here at the U of Utah in the 70's, 80's and 90's while working with Drs. Kolff ('father of artificial organs') and Moulopoulos (inventor of Intraaortic Balloon Pump - IABP). Inspired by the concept of using technology to replace biology they led important discoveries/patents and played a significant role in advancing the Mechanical Circulatory Support field through the pioneering of IABP, Paraaortic Counterpulsation (PULVAD) and the first Total Artificial Heart (TAH).

    In a similarly inspiring academic environment Dr. Drakos is guiding his lab and clinical teams focused on using technology to understand and manipulate biology with the goal being myocardial recovery. For clinical or research job opportunities please contact stavros.drakos@hsc.utah.edu (please include your CV and potential referees).

    For info regarding life in scenic Salt Lake City and Utah please visit: and

    RESEARCH SUPPORT/FUNDING:

    Dr. Drakos and his mentees have received over the years extensive extramural research funding and competitive scientific medical awards in the US and Europe from the NIH, AHA, Department of Veterans Affairs, European Union/EU Marie Curie, ISHLT, Doris Duke Foundation, Intermountain Research Medical Foundation, Leventis and Bodossakis Foundations and others.

    Specialties

    Board Certification

    Board Certified in Cardiology (European Union and European Commission Board Certification)
    European Society of Cardiology (Heart Failure Certification)

  • Dr. Stavros George Drakos is a Professor of Cardiology and Physiology at the 91Â鶹ÌìÃÀÖ±²¥ & School of Medicine and holds the H. A. & Edna Benning Presidential Endowed Chair. He is the Medical Director of our institution's historic Cardiac Mechanical Support/Artificial Heart Program, Co-Director of the Heart Failure & Transplant section and Director of Research for the Division of Cardiology. Dr. Drakos is one of 27 cardiologists in the country being recognized by Forbes as an exemplary physician in the field of Cardiology.

    Dr. Drakos and his team published clinical studies in heart failure together with original scientific work generated in the laboratory which led to the establishment of the award-winning Utah Cardiac Recovery Program (UCAR). He is the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH and a visiting professor in academic medical centers nationally and internationally. He co-chairs the annual international Utah Cardiac Recovery Symposium (UCARS), the NIH Working Group on Myocardial Recovery and is an elected member of the ASCI (American Society of Clinical Investigation). Dr. Drakos has mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas.

    CLINICAL INFO

    Dr. Drakos is one of 27 cardiologists across the country being recognized by Forbes as an exemplary physician in the field of Cardiology (for more info click ).

    Earlier in his career he completed advanced heart failure and transplant training at the U of Utah (2001-2003) and after returning to the U of Athens in Greece he played a pivotal role in starting the first Ventricular Assist Device (VAD) program in the country (2003-2008) in collaboration with Sir Magdi Yacoub's team, Harefield/Imperial College London. Six years later (2008) he was recruited back at the U of Utah and since then he has been on faculty at the Division of Cardiology.

    What kind of patients Dr. Drakos sees?

    Dr. Drakos’ clinical specialties include Heart Failure and Cardiomyopathies, Heart Transplantation and Mechanical Circulatory Support (MCS/VAD). He is licensed to practice medicine in the US and the EU. He currently receives patient referrals and consultations from several states. To schedule an appointment please call 801-585-5122. For 12 years in a row, 91Â鶹ÌìÃÀÖ±²¥ has been ranked in the top 10 for Health Care Quality among major university hospitals in the US: /quality/

    ACADEMIC INFO

    Dr. Drakos’ research interests are focused on cardiac recovery in the chronic heart failure (HF) setting and the acute setting (i. e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Dr. Drakos' NIH-funded team is housed at the Nora Eccles Harrison Cardiovascular Research and Training Institute-CVRTI (). Original work generated by Dr. Drakos' team in the clinical arena and in his lab led to the establishment of the award-winning multidisciplinary Utah Cardiac Recovery Program-UCAR. To further advance the field of cardiac recovery Dr. Drakos is co-directing the annual international Utah Cardiac Recovery Symposium (UCARS) - for more info click . Along the same lines Dr. Drakos is co-chairing the NIH/NHLBI Working Group on Myocardial Recovery - its executive summary and member list can be found at: https://www.nhlbi.nih.gov/events/2016/nhlbi-working-group-advancing-science-myocardial-recovery-mechanical-circulatory - simultaneous publication at the official journals of the American College Cardiology, Heart Failure Society of America, American Association of Thoracic Surgery and the American Society of Artificial Internal Organs.

    TRAINING:

    1. Dr. Drakos started his medical training at the Univ. of Athens School of Medicine (most competitive academic institution in Greece: ) where he was admitted after scoring 3rd highest out of thousands pre-med students on the state boards. He received his Medical Degree (M. D. ) with Honors and went on to acquire a Ph. D under the mentorship of John N. Nanas, MD/PhD, a prior trainee of the U of Utah (Thesis entitled: 'Pulsatile vs. non-pulsatile mechanical circulatory support in a porcine model of heart failure', Award: 'Top PhD Thesis of the Year, U of Athens')

    2. Internal Medicine and General Cardiology Training: U of Athens (Mentors: John N. Nanas, MD/PhD, and Maria Anastasiou-Nanas, MD/PhD).

    3. Heart Failure/Transplant/MCS Fellowship: U of Utah, Intermountain Healthcare & Salt Lake VA Medical Center (Mentors: Dale G. Renlund, MD, and Elizabeth H. Hammond, MD).

    4. Harefield-UK Athens-Greece Cardiac Recovery Program (H. A. R. P. ), (Mentor: Sir Magdi H. Yacoub, MD)

    5. Cardiovascular Translational Research Fellowship: Molecular Medicine Program / Eccles Institute of Human Genetics, U of Utah (Mentor: Dean Y. Li, MD/PhD).

    NOW HIRING - WHY IN THE ACADEMIC ENVIRONMENT OF UTAH:

    From a historical perspective Dr. Drakos’ mentors, John Nanas, MD/PhD and Alex Kralios, MD/PhD, also came from the U of Athens and excelled here at the U of Utah in the 70's, 80's and 90's while working with Drs. Kolff ('father of artificial organs') and Moulopoulos (inventor of Intraaortic Balloon Pump - IABP). Inspired by the concept of using technology to replace biology they led important discoveries/patents and played a significant role in advancing the Mechanical Circulatory Support field through the pioneering of IABP, Paraaortic Counterpulsation (PULVAD) and the first Total Artificial Heart (TAH).

    In a similarly inspiring academic environment Dr. Drakos is guiding his lab and clinical teams focused on using technology to understand and manipulate biology with the goal being myocardial recovery. For clinical or research job opportunities please contact stavros.drakos@hsc.utah.edu (please include your CV and potential referees).

    For info regarding life in scenic Salt Lake City and Utah please visit: and

    RESEARCH SUPPORT/FUNDING:

    Dr. Drakos and his mentees have received over the years extensive extramural research funding and competitive scientific medical awards in the US and Europe from the NIH, AHA, Department of Veterans Affairs, European Union/EU Marie Curie, ISHLT, Doris Duke Foundation, Intermountain Research Medical Foundation, Leventis and Bodossakis Foundations and others.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    Board Certified in Cardiology (European Union and European Commission Board Certification)
    European Society of Cardiology (Heart Failure Certification)

    Education history

    Fellowship Cardiovascular Translational Research Fellowship; Molecular Medicine Program- Director: Dean Y. Li, MD/PhD - University of Utah/ Eccles Institute of Human Genetics Fellow
    Fellowship Harefield Athens Recovery Program-HARP – Directors: Sir Magdi Yacoub, MD & John Nanas, MD/PhD - Harefield Heart Sciences Center/Imperial College London & University of Athens, Greece Fellow
    Fellowship Advanced Heart Failure Fellowship - Director: Dale G. Renlund, MD - UTAH Cardiac Transplant Program - 91Â鶹ÌìÃÀÖ±²¥; Intermountain Health; SLC VA Health Fellow
    Residency Internal Medicine - University of Athens Resident
    Doctoral Training Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Award Best 3 PhD Theses 2000-2005 – Mentor: John Nanas, MD/PhD - University of Athens Ph.D.
    Professional Medical Medicine, Summa Cum Laude - most competive academic institution in Greece and greater Balkan area - University of Athens M.D.

    Selected Publications

    Journal Article

    1. Kyriakopoulos CP, Horne BD, Sideris K, Taleb I, Griffin RJ, Sheffield E, Alharethi R, Hanff TC, Stehlik J, Selzman CH, Drakos SG (2023). Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support. J Heart Lung Transplant, 42(7), 853-858. ()
    2. Palatinus JA, Valdez S, Taylor L, Whisenant C, Selzman CH, Drakos SG, Ranjan R, Hong T, Saffitz JE, Shaw RM (2023). GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy. Circ Res, 132(6), 744-746. ()
    3. Hanff TC, Browne A, Dickey J, Gaines H, Harhay MO, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J (2022). Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients. J Heart Lung Transplant, 42(3), 368-376. ()
    4. Browne A, Gaines H, Alharethi R, Goodwin M, Selzman CH, Fang JC, Drakos SG, Stehlik J, Hanff TC (2022). Interrupted Time Series Analysis of Donor Heart Use Before and After the 2018 UNOS Heart Allocation Policy Change. J Card Fail, 29(2), 220-224. ()
    5. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin S (2022). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424. ()
    6. Jentzer JC, Baran DA, Kyle Bohman J, van Diepen S, Radosevich M, Yalamuri S, Rycus P, Drakos SG, Tonna JE (2022). Cardiogenic shock severity and mortality in patients receiving venoarterial extracorporeal membrane oxygenator support. Eur Heart J Acute Cardiovasc Care, 11(12), 891-903. ()
    7. Felker GM, Buttrick P, Rosenzweig A, Abel ED, Allen LA, Bristow M, Das S, DeVore AD, Drakos SG, Fang JC, Freedman JE, Hernandez AF, Li DY, McKinsey TA, Newton-Cheh C, Rogers JG, Shah RV, Shah SH, Stehlik J, Selzman CH (2022). Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions. J Am Heart Assoc, 11(18), e025517. ()
    8. Knox DB, Lanspa MJ, Wilson E, Haaland B, Beesley S, Hirshberg E, Abraham TP, Vallabhajosyula S, Grissom CK, Drakos SG, Brown SM (2021). Initial Derivation of a Predictive Model for Left Ventricular Longitudinal Strain (LS) in Early Sepsis. J Intensive Care Med, 37(8), 1049-1054. ()
    9. Kapelios CJ, Lund LH, Wever-Pinzon O, Selzman CH, Myers SL, Cantor RS, Stehlik J, Chamogeorgakis T, McKellar SH, Koliopoulou A, Alharethi R, Kfoury AG, Bonios M, Adamopoulos S, Gilbert EM, Fang JC, Kirklin JK, Drakos SG (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circ Heart Fail, 15(6), e008706. ()
    10. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D (2022). Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat Commun, 13(1), 2769. ()
    11. Topkara VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, Takeda K, Takayama H, Selzman CH, Naka Y, Burkhoff D, Stehlik J, Farr MA, Fang JC, Uriel N, Drakos SG (2021). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. J Am Coll Cardiol, 79(9), 900-913. ()
    12. Sommakia S, Almaw NH, Lee SH, Ramadurai DKA, Taleb I, Kyriakopoulos CP, Stubben CJ, Ling J, Campbell RA, Alharethi RA, Caine WT, Navankasattusas S, Hoareau GL, Abraham AE, Fang JC, Selzman CH, Drakos SG, Chaudhuri D (2021). FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure. Circ Heart Fail, 15(3), e008910. ()
    13. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos SG (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheter Cardiovasc Interv, 98(7), 1275-1284. ()
    14. Sankarankutty AC, Greiner J, Bragard J, Visker JR, Shankar TS, Kyriakopoulos CP, Drakos SG, Sachse FB (2021). Etiology-Specific Remodeling in Ventricular Tissue of Heart Failure Patients and Its Implications for Computational Modeling of Electrical Conduction. Front Physiol, 12, 730933. ()
    15. Rorris FP, Antonopoulos CN, Kyriakopoulos CP, Drakos SG, Charitos C (2021). Implantable cardioverter defibrillators in left ventricular assist device patients: Α systematic review and meta-analysis. J Heart Lung Transplant, 40(10), 1098-1106. ()
    16. Healy AH, Bowen M, McKellar SH, Koliopoulou A, Drakos SG, Selzman CH (2021). Interleukin-1 Receptor Antagonism as Adjunct Therapy for Heart Failure Patients with Left Ventricular Assist Devices. ASAIO J, 67(8), e145-e147. ()
    17. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J (2021). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol, 6(8), 957-962. ()
    18. Kampaktsis PN, Tzani A, Doulamis IP, Moustakidis S, Drosou A, Diakos N, Drakos SG, Briasoulis A (2021). State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database. Clin Transplant, 35(8), e14388. ()
    19. Shankar TS, Ramadurai DKA, Steinhorst K, Sommakia S, Badolia R, Thodou Krokidi A, Calder D, Navankasattusas S, Sander P, Kwon OS, Aravamudhan A, Ling J, Dendorfer A, Xie C, Kwon O, Cheng EHY, Whitehead KJ, Gudermann T, Richardson RS, Sachse FB, Schredelseker J, Spitzer KW, Chaudhuri D, Drakos SG (2021). Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis. Nat Commun, 12(1), 4583. ()
    20. Lyu Y, Verma VK, Lee Y, Taleb I, Badolia R, Shankar TS, Kyriakopoulos CP, Selzman CH, Caine W, Alharethi R, Navankasattusas S, Seidel T, Drakos SG, Sachse FB (2021). Remodeling of t-system and proteins underlying excitation-contraction coupling in aging versus failing human heart. NPJ Aging Mech Dis, 7(1), 16. ()
    21. Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski ED (2021). Short-Chain Fatty Acids Outpace Ketone Oxidation in the Failing Heart. Circulation, 143(18), 1797-1808. ()
    22. Shah P, Psotka M, Taleb I, Alharethi R, Shams MA, Wever-Pinzon O, Yin M, Latta F, Stehlik J, Fang JC, Diao G, Singh R, Ijaz N, Kyriakopoulos CP, Zhu W, May CW, Cooper LB, Desai SS, Selzman CH, Kfoury AG, Drakos SG (2021). Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages. Circ Heart Fail, 14(5), e007991. ()
    23. Hydren JR, Gifford JR, Jarrett CL, Park SH, Shields KL, Broxterman RM, Kithas AC, Bisconti AV, Thurston TS, Ratchford SM, Wray DW, Stehlik J, Selzman CH, Drakos SG, Richardson RS (2021). Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session. Am J Physiol Regul Integr Comp Physiol, 320(4), R425-R437. ()
    24. Hoffman M, Palioura D, Kyriazis ID, Cimini M, Badolia R, Rajan S, Gao E, Nikolaidis N, Schulze PC, Goldberg IJ, Kishore R, Yang VW, Bannister TD, Bialkowska AB, Selzman CH, Drakos SG, Drosatos K (2021). Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation, 143(11), 1139-1156. ()
    25. Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, Olson KA, Taleb I, Tatum SM, Berg JA, Cunningham CN, Van Ry T, Bott AJ, Krokidi AT, Fogarty S, Skedros S, Swiatek WI, Yu X, Luo B, Merx S, Navankasattusas S, Cox JE, Ducker GS, Holland WL, McKellar SH, Rutter J, Drakos SG (2020). The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab, 33(3), 629-648.e10. ()
    26. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J (2021). Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun, 12(1), 873. ()
    27. Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, Trivedi J, Slaughter MS, Alturi P, Goldstein D, Maybaum S, Um JY, Margulies KB, Stehlik J, Cunningham C, Farrar DJ, Rame JE (2020). Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation, 142(21), 2016-2028. ()
    28. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou L (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO J, 66(10), e128-e130. ()
    29. Frey C, Koliopoulou AG, Montenont E, Tolley ND, Javan H, McKellar SH, Drakos SG, Selzman CH, Rondina MT (2020). Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading. Platelets, 31(7), 952-959. ()
    30. Lobo AS, Sandoval Y, Henriques JP, Drakos SG, Taleb I, Bagai J, Cohen MG, Chatzizisis YS, Sun B, Hryniewicz K, Eckman PM, Thiele H, Brilakis ES (2020). Cardiogenic Shock Management: International Survey of Contemporary Practices. J Invasive Cardiol, 32(10), 371-374. ()
    31. Taleb I, Wever-Pinzon J, Wang W, Koliopoulou A, Dranow E, Yu T, Yin L, McKellar SH, Stehlik J, Fang JC, Wever-Pinzon O, Selzman CH, Drakos SG (2019). Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis. Heart Lung Circ, 29(8), 1226-1233. ()
    32. Bunsawat K, Ratchford SM, Alpenglow JK, Park SH, Jarrett CL, Stehlik J, Drakos SG, Richardson RS, Wray DW (2020). Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction. Exp Physiol, 105(8), 1384-1395. ()
    33. Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos SG (2020). The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Circulation, 142(3), 259-274. ()
    34. Oka SI, Sabry AD, Horiuchi AK, Cawley KM, OVery SA, Zaitsev MA, Shankar TS, Byun J, Mukai R, Xu X, Torres NS, Kumar A, Yazawa M, Ling J, Taleb I, Saijoh Y, Drakos SG, Sadoshima J, Warren JS (2020). Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1. PLoS One, 15(6), e0234913. ()
    35. Hydren JR, Cornwell WK 3rd, Richardson RS, Drakos SG (2020). Exercise Capacity in Mechanically Supported Advanced Heart Failure Patients: It Is All About the Beat. ASAIO J, 66(4), 339-342. ()
    36. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2019). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail, 8(4), 302-312. ()
    37. Riehle C, Weatherford ET, Wende AR, Jaishy BP, Seei AW, McCarty NS, Rech M, Shi Q, Reddy GR, Kutschke WJ, Oliveira K, Pires KM, Anderson JC, Diakos NA, Weiss RM, White MF, Drakos SG, Xiang YK, Abel ED (2020). Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. JCI Insight, 5(6). ()
    38. Hydren JR, Kithas AC, Park SH, Wever-Pinzon O, Selzman CH, Perry W, Vargas CAS, Stehlik J, Drakos SG, Richardson RS (2019). Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed. ASAIO J, 66(3), 291-299. ()
    39. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou L (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO J. ()
    40. Ko B, Drakos SG, Ibrahim H, Kang TS, Thodou A, Bonios M, Taleb I, Welt FG (2020). Percutaneous Mechanical Unloading Simultaneously With Reperfusion Induces Increased Myocardial Salvage in Experimental Acute Myocardial Infarction. Circ Heart Fail, 13(1), e005893. ()
    41. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869. ()
    42. Symons JD, Deeter L, Deeter N, Bonn T, Cho JM, Ferrin P, McCreath L, Diakos NA, Taleb I, Alharethi R, McKellar S, Wever-Pinzon O, Navankasattusas S, Selzman CH, Fang JC, Drakos SG (2019). Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy. Circ Heart Fail, 12(8), e006085. ()
    43. Iosif Taleb, Antigone G Koliopoulou, Anwar Tandar, Stephen H McKellar, Joseph E Tonna, Jose Nativi-Nicolau, Miguel Alvarez Villela, Frederick Welt, Josef Stehlik, Edward M Gilbert, Omar Wever-Pinzon, Jack H Morshedzadeh, Elizabeth Dranow, Craig H Selzman, James C Fang, Stavros G Drakos (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circ Heart Fail, 140(1), 98-100.
    44. Uriel N, Burkhoff D, Rich JD, Drakos SG, Teuteberg JJ, Imamura T, Rodgers D, Raikhelkar J, Vorovich EE, Selzman CH, Kim G, Sayer G (2019). Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circ Heart Fail, 12(4), e006067. ()
    45. Hickman AW, Lonardo NW, Mone MC, Presson AP, Zhang C, Barton RG, Selzman CH, Drakos SG, Koliopoulou A, McKellar SH (2018). Acid Suppression to Prevent Gastrointestinal Bleeding in Patients With Ventricular Assist Devices. J Surg Res, 234, 96-102. ()
    46. Drakos SG, Pagani FD, Lundberg MS, Baldwin JT (2017). Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute. JACC Basic Transl Sci, 2(3), 335-340. ()
    47. Drakos SG, Pagani FD, Lundberg MS, Baldwin JT (2017). Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute. J Card Fail, 23(5), 416-421. ()
    48. Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos SG (2016). Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading. J Am Coll Cardiol, 68(16), 1741-1752. ()
    49. Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH (2016). Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. J Am Coll Cardiol, 68(14), 1540-53. ()
    50. Kfoury AG, Miller DV, Snow GL, Afshar K, Stehlik J, Drakos SG, Budge D, Fang JC, Revelo MP, Alharethi RA, Gilbert EM, Caine WT, McKellar S, Molina KM, Hammond MEH (2015). Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. J Heart Lung Transplant, 35(3), 335-341. ()
    51. Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH (2016). Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices--An analysis of the International Society for Heart and Lung Transplantation Transplant Registry. J Heart Lung Transplant, 35(1), 34-39. ()
    52. Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Richardson R, Deberardinis R, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos SG (2016). Evidence of glycolysis upregulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC Basic Transl Sci.
    53. Drakos SG, Mehra MR (2016). Clinical myocardial recovery during long-term mechanical support in advanced heart failure: insights into moving the field forward. J Heart Lung Transplant, 35(4), 413-20.
    54. Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson RS (2015). Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC Heart Fail, 3(9), 703-11. ()
    55. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos SG (2015). Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? Clin Transplant, 29(9), 829-34. ()
    56. Hong K, Jeong EK, Wall TS, Drakos SG, Kim D (2015). Wideband arrhythmia-Insensitive-rapid (AIR) pulse sequence for cardiac T1 mapping without image artifacts induced by an implantable-cardioverter-defibrillator. Magn Reson Med, 74(2), 336-45. ()
    57. Healy AH, Koliopoulou A, Drakos SG, McKellar SH, Stehlik J, Selzman CH (2015). Patient-controlled conditioning for left ventricular assist device-induced myocardial recovery. Ann Thorac Surg, 99(5), 1794-6. ()
    58. Selzman CH, Madden JL, Healy AH, McKellar SH, Koliopoulou A, Stehlik J, Drakos SG (2015). Bridge to removal: a paradigm shift for left ventricular assist device therapy. Ann Thorac Surg, 99(1), 360-7. ()
    59. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed, 27(11), 1378-86. ()
    60. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. J Am Coll Cardiol, 64(15), 1602-12. ()
    61. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH (2014). Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO J, 60(5), 524-8. ()
    62. Park SY, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS, Diakos NA, Ives SJ, Dela F, Larsen S, Drakos S, Richardson RS (2014). Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal? Am J Physiol Heart Circ Physiol, 307(3), H346-52. ()
    63. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Pia IL, Kfoury AG, Garcia MJ, Stehlik J (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol, 63(19), 1992-2004. ()
    64. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg, 97(4), 1364-71; discussion 1371-2. ()
    65. Omar Wever-Pinzon, Jorge Romero, Iosif Kelesidis, James Wever-Pinzon, Carlos Manrique, Deborah Budge, Drakos SG, Ileana Pina, Abdallah G Kfoury, Mario J Garcia, Josef Stehlik (3/2014). Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials ONLINE FIRST. J Am Coll Cardiol.
    66. Frech T, De Domenico I, Murtaugh MA, Revelo MP, Li DY, Sawitzke AD, Drakos SG (2014). Autophagy is a key feature in the pathogenesis of scytemic sclerosis. Rheumatol Int, 34(3), 435-439.
    67. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG, UCAR Utah Cardiac Recovery Program Investigators (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94. ()
    68. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail, 6(3), 517-26. ()
    69. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Drakos SG (2013). Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol, 62(23), 2257-8.
    70. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5. ()
    71. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62. ()
    72. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol, 21(6), 445-54. ()
    73. Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN (2012). Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Int J Cardiol, 159(3), 225-9. ()
    74. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41. ()
    75. Frech TM, Revelo MP, Drakos SG, Murtaugh MA, Markewitz BA, Sawitzke AD, Li DY (2012). Vascular leak is a central feature in the pathogenesis of systemic sclerosis. J Rheumatol, 39(7), 1385-91. ()
    76. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther, 134(2), 189-99. ()
    77. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman CH (2012). Improved survival in heart transplant patients living at high altitude. J Thorac Cardiovasc Surg, 143(3), 735-741.e1. ()
    78. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51. ()
    79. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, Katsaros L, Drakos S, Terrovitis J, Nanas S (2011). Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing Clin Electrophysiol, 34(12), 1607-14. ()
    80. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61. ()
    81. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607. ()
    82. Pierrakos CN, Bonios MJ, Drakos SG, Charitos EI, Tsolakis EJ, Ntalianis A, Nanas SN, Charitos CE, Nanas JN, Terrovitis JV (2011). Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs, 35(9), 867-74. ()
    83. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61. ()
    84. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest, 121(5), 1871-81. ()
    85. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol, 26(3), 245-55. ()
    86. Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, Diakos N, Koudoumas D, Theodoropoulos S, Yacoub MH, Anastasiou-Nana MI (2011). Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg, 91(3), 764-9. ()
    87. Stavrakis S, Terrovitis J, Tsolakis E, Drakos S, Dalianis A, Bonios M, Koudoumas D, Malliaras K, Nanas J (2011). Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Transl Res, 4(1), 99-105. ()
    88. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG (2010). End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant, 29(12), 1337-41. ()
    89. Verma DR, Drakos SG, Stehlik J, Horne BD, Kfoury AG (2010). Effect of preservation solution choice on antibody-mediated rejection after heart transplantation. J Heart Lung Transplant, 29(11), 1314-5. ()
    90. Singhal AK, Drakos SG, Kfoury AG, Horne BD, Verma DR, Stehlik J (2010). Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection. J Heart Lung Transplant, 29(10), 1198-200. ()
    91. Tasoulis A, Papazachou O, Dimopoulos S, Gerovasili V, Karatzanos E, Kyprianou T, Drakos S, Anastasiou-Nana M, Roussos C, Nanas S (2010). Effects of interval exercise training on respiratory drive in patients with chronic heart failure. Respir Med, 104(10), 1557-65. ()
    92. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Kfoury AG (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc, 42(7), 2687-92. ()
    93. Dimopoulos SK, Drakos SG, Terrovitis JV, Tzanis GS, Nanas SN (2010). Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant, 29(8), 906-8. ()
    94. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91. ()
    95. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg, 140(1), 169-73. ()
    96. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW (2010). Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol, 105(7), 1030-5. ()
    97. Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, Drakos SG, Koudoumas D, Charitos CE, Anastasiou-Nana MI (2010). Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. Int J Cardiol, 138(3), 253-60. ()
    98. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN (2010). Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging, 3(1), 64-70. ()
    99. Singhal AK, Sheng X, Drakos SG, Stehlik J (2009). Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc, 41(9), 3539-44. ()
    100. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, Tasoulis A, Anastasiou-Nana M, Roussos C, Nanas S (2009). Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm Rehabil Prev, 29(6), 385-91. ()
    101. Kanakakis J, Nanas JN, Tsagalou EP, Maroulidis GD, Drakos SG, Ntalianis AS, Tzoumele P, Skoumbourdis E, Charbis P, Rokas S, Anastasiou-Nana M (2009). Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Catheter Cardiovasc Interv, 74(3), 398-405. ()
    102. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas JN (2009). Long-term survival and outcomes after hospitalization for acute myocardial infarction complicated by cardiogenic shock. Clin Cardiol, 32(8), E4-8. ()
    103. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42. ()
    104. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009). Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 28(8), 781-4. ()
    105. Malliaras KG, Terrovitis JV, Drakos SG, Nanas JN (2009). Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res, 2(1), 114-25. ()
    106. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN (2009). Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. J Cardiovasc Pharmacol, 53(2), 157-61. ()
    107. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med, 15(2), 177-84. ()
    108. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN (2009). Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care, 11(2), 99-106. ()
    109. Ntalianis AS, Drakos SG, Charitos C, Dolou P, Pierrakos CN, Terrovitis JV, Papaioannou T, Charitos E, Nanas JN (2008). Effects of intra-aortic balloon pump versus centrifugal pump on myocardial energetics and systemic circulation in a porcine model of rapidly worsening acute heart failure. ASAIO J, 54(6), 600-5. ()
    110. Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN (2008). Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis? Coron Artery Dis, 19(7), 521-6. ()
    111. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN (2008). Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 52(17), 1391-8. ()
    112. Strber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince P (2008). HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg, 34(2), 289-94. ()
    113. Kravari M, Vasileiadis I, Gerovasili V, Karatzanos E, Tasoulis A, Kalligras K, Drakos SG, Dimopoulos S, Anastasiou-Nana M, Nanas S (2008). Effects of a 3-month rehabilitation program on muscle oxygenation in congestive heart failure patients as assessed by NIRS.
    114. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Horne BD, Hagan MB, Nelson K, Renlund DG (2007). Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure. Eur J Heart Fail, 9(8), 845-9. ()
    115. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG (2007). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg, 133(6), 1612-9. ()
    116. Papazachou O, Anastasiou-Nana M, Sakellariou D, Tassiou A, Dimopoulos S, Venetsanakos J, Maroulidis G, Drakos S, Roussos C, Nanas S (2007). Pulmonary function at peak exercise in patients with chronic heart failure. Int J Cardiol, 118(1), 28-35. ()
    117. Drakos SG, Charitos EI, Nanas SN, Nanas JN (2007). Ventricular-assist devices for the treatment of chronic heart failure. Expert Rev Cardiovasc Ther, 5(3), 571-84. ()
    118. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, Campbell BA, Renlund DG (2007). Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 26(4), 319-23. ()
    119. Drakos SG, Kfoury AG, Gilbert EM, Long JW, Stringham JC, Hammond EH, Jones KW, Bull DA, Hagan ME, Folsom JW, Horne BD, Renlund DG (2007). Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg, 83(1), 62-7. ()
    120. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006). Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol, 48(12), 2485-9. ()
    121. Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006). Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg, 82(3), 889-93. ()
    122. Nanas SN, Nanas JN, Sakellariou DCh, Dimopoulos SK, Drakos SG, Kapsimalakou SG, Mpatziou CA, Papazachou OG, Dalianis AS, Anastasiou-Nana MI, Roussos C (2006). VE/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. Eur J Heart Fail, 8(4), 420-7. ()
    123. Terrovitis JV, Anastasiou-Nana MI, Alexopoulos GP, Tsolakis EJ, Margari ZJ, Drakos SG, Tsagalou EP, Papazoglou P, Efentakis S, Nanas JN (2006). Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant, 25(3), 333-8. ()
    124. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Moore SA, Campbell BK, Nelson KE, Horne BD, Renlund DG (2006). Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant, 25(1), 22-8. ()
    125. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, Drakos SG, Kapsimalakou S, Maroulidis G, Roditis P, Roussos C, Nanas S (2006). Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil, 13(1), 67-73.
    126. Anastasiou-Nana MI, Tsagalou EP, Mavrikakis EM, Siafakas KX, Tsolakis EJ, Drakos SG, Dalianis A, Karelas J, Terrovitis JV, Nanas JN (2005). Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds. Resuscitation, 64(3), 373-6. ()
    127. Anastasiou-Nana MI, Tsagalou EP, Charitos C, Siafakas KX, Drakos S, Terrovitis JV, Ntalianis A, Doufas A, Mavrikakis J, Nanas JN (2005). Effects of transient myocardial ischemia on the ventricular defibrillation threshold. Pacing Clin Electrophysiol, 28(2), 97-101. ()
    128. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P, Pierrakos C, Charitos E, Karelas J, Nanas JN (2005). Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO J, 51(1), 26-9. ()
    129. Tsagalou EP, Anastasiou-Nana MI, Charitos CE, Siafakas CX, Drakos SG, Ntalianis A, Terrovitis JV, Mavrikakis EM, Doufas A, Nanas JN (2004). Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. Resuscitation, 61(1), 83-9. ()
    130. Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos CE (2004). Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest, 125(4), 1492-9. ()
    131. Drakos SG, Papamichael CM, Alexopoulos GP, Anastasiou-Nana MI, Stathopoulos JV, Nanas JN (2003). Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol, 91(7), 885-8. ()
    132. Nanas S, Nanas J, Kassiotis C, Nikolaou C, Tsagalou E, Sakellariou D, Terovitis I, Papazachou O, Drakos S, Papamichalopoulos A, Roussos C (2001). Early recovery of oxygen kinetics after submaximal exercise test predicts functional capacity in patients with chronic heart failure. Eur J Heart Fail, 3(6), 685-92. ()
    133. Drakos SG, AnastasiouNana M, Nanas J (2001). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. Int J Cardiol, 82, 83-85.
    134. Ziras N, Rozakou A, Skoura S, Drakos S, Venetsanou V, Tsiggalakis D, Fragaki 924, Giannakakis T, Athanassiou A (2001). Soluble transferrin receptor: An early predicting index of response to epoetin alfa treatment for the prophylaxis of chemotherapy-induced anemia in patients with solid tumors. J BUON, 6, 67-73.

    Review

    1. Tseliou E, Lavine KJ, Wever-Pinzon O, Topkara VK, Meyns B, Adachi I, Zimpfer D, Birks EJ, Burkhoff D, Drakos SG (2022). Biology of myocardial recovery in advanced heart failure with long-term mechanical support. [Review]. J Heart Lung Transplant, 41(10), 1309-1323. ()
    2. Bonios MJ, Armenis I, Kogerakis N, Thodou A, Gkouziouta A, Koliopoulou A, Kaklamanis L, Chamogeorgakis T, Drakos SG, Adamopoulos SN (2022). Phenotype Characterization and Course of Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Biventricular Advanced Heart Failure: A Report of 3 Cases. [Review]. Transplant Proc, 54(8), 2347-2351. ()
    3. Tehrani BN, Drakos SG, Billia F, Batchelor WB, Luk A, Stelling K, Tonna J, Rosner C, Hanff T, Rao V, Brozzi NA, Baran DA (2022). The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design. [Review]. Can J Cardiol, 38(8), 1286-1295. ()
    4. Kyriakopoulos CP, Kapelios CJ, Stauder EL, Taleb I, Hamouche R, Sideris K, Koliopoulou AG, Bonios MJ, Drakos SG (2022). LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement. [Review]. J Clin Med, 11(12). ()
    5. Taleb I, Tseliou E, Fang JC, Drakos SG (2022). A Mechanical Bridge to Recovery as a Bridge to Discovery: Learning From Few and Applying to Many. [Review]. Circulation, 145(8), 562-564. ()
    6. Shah KS, Hale Hammond ME, Drakos SG, Anderson JL, Fang JC, Knowlton KU, Shaw RM (2021). SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges. [Review]. Future Cardiol, 17(7), 1277-1291. ()
    7. Hammond MEH, Stehlik J, Drakos SG, Kfoury AG (2021). Bias in Medicine: Lessons Learned and Mitigation Strategies. [Review]. JACC Basic Transl Sci, 6(1), 78-85. ()
    8. Wever-Pinzon O, Drakos SG, Fang JC (2015). Team-based Care for Advanced Heart Failure. [Review]. Heart Fail Clin, 11(3), 467-77. ()
    9. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN (2009). Anemia in chronic heart failure. [Review]. Congest Heart Fail, 15(2), 87-92. ()
    10. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN, Nanas JN (2009). Anemia in heart failure: pathophysiologic insights and treatment options. [Review]. Future Cardiol, 5(1), 71-81. ()
    11. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN (2007). Reverse remodeling during long-term mechanical unloading of the left ventricle. [Review]. J Mol Cell Cardiol, 43(3), 231-42. ()

    Book Chapter

    1. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos SG (2013). Mechanical unloading and heart remodeling features. In Edmo Gabriel, Sthefano Gabriel (Eds.), Inflammatory response in cardiovascular surgery, New York, NY: Springer.
    2. Terrovitis JV, Tseliou E, Drakos SG, Nanas JN (2011). Evaluation of Cardiac Function after VAD Implantation, New Aspects of Ventricular Assist Devices, Guillermo Reyes (Ed.), ISBN: 978-953-307-676-8, InTech, Available from : http://www.intechopen.com/books.
    3. Tsagalou EP, Drakos SG, Tsolakis E, Nanas J (2008). Intra-aortic balloon pump in the management of acute heart failure syndromes. In Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph Parrillo (Eds.), Acute Heart Failure (pp. 671-684). New York, NY: Springer.
    4. Drakos SG, Alexopoulos G, Nanas JN (2005). Organizing a heart failure program. In Filippatos G, Adamopoulos S, Parissis J, Anthopoulos L, Kremastinos D (Eds.), Heart Failure: from diagnosis to treatment (pp. 453-464). Athens, Greece: Paschalides Editions.

    Conference Proceedings

    1. Drakos SG, Bonios M, Terrovitis JV, Panagiotopoulos G, Pozios I, Diakos N, Tseliou E, Malliaras K, Kanakakis J, Anastasiou-Nana MI (2009). Commonly used risk factors failed to accurately predict survival in patients with advanced heart failure. (Indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 14th World Congress on Heart Disease, 251.
    2. Bonios M, Drakos SG, Anastasiou-Nana M, Tsagalou E, Ntalianis A, Maroulidis G, Venetsanakos J, Lazaris N, Kanakakis J, Nanas J (2007). Prognosis of Post-Myocardial Infarction Cardiogenic Shock Patients that Require Mechanical Ventilation. (indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 13th World Congress on Heart Dis, XV, 383-7.

    Editorial

    1. Kyriakopoulos CP, Taleb I, Drakos SG (2022). Does cardiac recovery favorably impact adverse events and outcomes of LVAD patients? J Heart Lung Transplant, 41(8), 1029-1031. ()
    2. Bonios MJ, Tseliou E, Drakos SG (2020). Commentary: Major lessons from minor people: Beta blockers and cytokinesis in tetralogy of Fallot. J Thorac Cardiovasc Surg, 161(5), 1592-1593. ()
    3. Koliopoulou AG, Bonios MJ, Diakos NA, Drakos SG (2021). Biventricular failure and total artificial heart: Old and new solutions for a vexing problem. Hellenic J Cardiol, 61(6), 413-414. ()
    4. Hydren JR, Richardson RS, Wever-Pinzon O, Drakos SG (2019). The "double whammy" of a continuous-flow left ventricular assist device on von Willebrand factor. J Thorac Cardiovasc Surg, 159(3), 910-915. ()
    5. Bonios MJ, Adamopoulos SN, Drakos SG (2020). Quality matters: Erectile dysfunction and cardiac resynchronization therapy. Hellenic J Cardiol, 61(1), 40-41. ()
    6. Tandar A, Drakos SG (2019). Cardiogenic shock in aortic stenosis patients: Balancing between complexity and simplicity. Hellenic J Cardiol, 60(3), 182-184. ()
    7. Drakos SG, Pagani FD, Lundberg MS, Baldwin TJ (2017). Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute. J Thorac Cardiovasc Surg, 154(1), 165-170. ()
    8. Drakos SG (2017). Combining Left Ventricular Volume Reduction Techniques With Cell Therapies: Quo Vadis? Hellenic J Cardiol, 58(2), 133-134. ()
    9. Drakos SG, Mehra MR (2016). Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward. J Heart Lung Transplant, 35(4), 413-20. ()
    10. Uriel N, Drakos SG (2015). Spotlight on new therapies in heart failure. Curr Opin Cardiol, 30(3), 246-9. ()
    11. Shah RU, Stehlik J, Drakos SG, Fang JC (2015). Administrative data: proceed with caution. J Am Coll Cardiol, 65(10), 1063. ()
    12. Drakos SG (2014). The odyssey of chronic cardiac mechanical support. J Am Coll Cardiol, 63(17), 1758-60. ()
    13. Drakos SG, Uriel N (2014). Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support. Curr Opin Cardiol, 29(3), 241-3. ()
    14. Drakos SG (2014). The Odyssey of Chronic Cardiac Mechanical Support. J Am Coll Cardiol, Feb 27.

    Letter

    1. Kapelios CJ, Drakos SG, Fang JC (2022). Acute Decompensated Heart Failure, Volume, and Acetazolamide. [Letter to the editor]. N Engl J Med, 387(26), 2486. ()
    2. Pana TA, Savla J, Kepinski I, Fairbourn A, Afzal A, Mammen P, Drazner M, Subramaniam RM, Xing C, Morton KA, Drakos SG, Zaha VG, Sadek HA (2022). Bidirectional Changes in Myocardial (18)F-Fluorodeoxyglucose Uptake After Human Ventricular Unloading. [Letter to the editor]. Circulation, 145(2), 151-154. ()
    3. Birks EJ, Rame JE, Cunningham C, Drakos SG (2021). Response by Birks et al to Letters Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results". [Letter to the editor]. Circulation, 143(22), e1017-e1018. ()
    4. Yin MY, Tandar A, Sharma V, Glotzbach JP, Shah RU, Dranow E, Tseliou E, Fang JC, Drakos SG, Welt FGP (2019). Left Ventricular Hemodynamic Changes During Transcatheter Aortic Valve Replacement Assessed by Real-Time Pressure-Volume Loops. [Letter to the editor]. JACC Cardiovasc Interv, 13(18), 2190-2192. ()
    5. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. [Letter to the editor]. Circulation, 140(1), 98-100. ()
    6. Diakos NA, Selzman CH, Stehlik J, Sachse FB, Kfoury AG, Koliopoulou A, McKellar S, Fang JC, Li DY, Drakos SG (2015). Reply: does size matter? In search of a physiological definition of myocardial atrophy. [Letter to the editor]. J Am Coll Cardiol, 65(19), 2156-7. ()
    7. Shah RU, Stehlik J, Drakos SG, Fang JC (2014). Administrative data: proceed with caution. [Letter to the editor]. J Am Coll Cardiol, 65(10), 1063. ()
    8. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos SG (2013). Reply: left ventricular assist devices in chronic heart failure: more questions than answers? [Letter to the editor]. J Am Coll Cardiol, 62(23), 2257-8. ()
    9. Drakos SG, Anastasiou-Nana MI, Nanas JN (2002). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. [Letter to the editor]. Int J Cardiol, 82(1), 83-5. ()

    Other

    1. Maron BA, Wang RS, Shevtsov S, Drakos SG, Arons E, Wever-Pinzon O, Huggins GS, Samokhin AO, Oldham WM, Aguib Y, Yacoub MH, Rowin EJ, Maron BJ, Maron MS, Loscalzo J (2022). Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes. Nat Commun (13(1), p. 7026). England. ()
    2. Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D (2022). Author Correction: Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat Commun (13(1), p. 3532). England. ()
    3. Jain P, Shehab S, Muthiah K, Robson D, Granegger M, Drakos SG, Jansz P, Macdonald PS, Hayward CS (2019). Insights Into Myocardial Oxygen Consumption, Energetics, and Efficiency Under Left Ventricular Assist Device Support Using Noninvasive Pressure-Volume Loops. Circ Heart Fail (12(10), pp. e006191). United States. ()

  • News & Podcasts

    News

    Podcasts